MIS (Kawasaki-like multisystem inflammatory syndrome) as a manifestation of SARS-CoV-2 in newborns: a review of the literature
DOI:
https://doi.org/10.15574/SP.2023.136.106Keywords:
newborns, COVID-19, coronavirus disease caused by the virus SARS-CoV-2, Kawasaki-like multisystem inflammatory syndrome, MIS, clinical course, complication, mother-fetus-newborn systemAbstract
The coronavirus disease (COVID-19) has become a global problem for countries all over the world. People of all age groups are prone to infection and newborns make no exception.
Рurpose - to analyze and summarize information on the characteristics of the course, clinical manifestations, complications and ways to overcome coronavirus infection in newborns from mothers who contracted COVID-19 during pregnancy.
The results of clinical observations of this pathology in the perinatal period are of particular interest to doctors of related specialties, because the question simultaneously concerns the life of the mother and her child. The article in particular is an attempt to tackle changes in the “mother–fetus–newborn” system under the influence of the virus. SARS-CoV-2 causes a clinical syndrome in babies, called Multisystem Inflammatory Syndrome in Newborns and Children (MIS-N, MIS-C - Multisystem Inflammatory Syndrome - depending on the age of the child). It occurs after an acute infection with COVID-19, the clinical picture is very similar to Kawasaki disease and manifestations of multiple organs failure in infants. The article analyzes the latest data from foreign and domestic literature of publicly available scientific sources, which present modern views on the clinical features of the course of COVID-19 in the context of Kawasaki-like multisystem inflammatory syndrome in newborns, summarizes the issues of etiology, pathogenesis, features of clinical manifestations of coronavirus infection in newborns, as well as diagnosis and disease management options in the neonatal period.
No conflict of interests was declared by the authors.
References
Alsaied T, Tremoulet AH, Burns JC et al. (2021). Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation. 143 (1): 78-88. https://doi.org/10.1161/CIRCULATIONAHA.120.049836; PMid:33166178
Belhadjer Z, Méot M, Bajolle F et al. (2020). Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic. Circulation. 142: 429-436. https://doi.org/10.1161/CIRCULATIONAHA.120.048360; PMid:32418446
Blondiaux E, Pauline P, Redheuil A et al. (2020). Cardiac MRI in Children with Multisystem Inflammatory Syndrome Associated with COVID-19. Radiology. 297; 3: 283-288. https://doi.org/10.1148/radiol.2020202288; PMid:32515676 PMCid:PMC7294821
Boiko OI. (2015). Kawasaki systemic vasculitis: current state of the problem. Heart and blood vessels. 1: 92-98. ISSN 1727-5717.
Brodin P. (2020). Why is COVID-19 so mild in children? Acta Paediatr. 109 (6): 1082-1083. https://doi.org/10.1111/apa.15271; PMid:32212348
Cao Q, Chen Y, Chen C, Chiu C. (2020). SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. J. Formos. Med. Assoc. 119 (3): 670-673. https://doi.org/10.1016/j.jfma.2020.02.009; PMid:32139299 PMCid:PMC7126646
Carlotti A, Carvalho WB, Johnston CJ et al. (2020). COVID-19 diagnostic and management protocol for pediatric patients. Clinics. 75: e1894. https://doi.org/10.6061/clinics/2020/e1894; PMid:32321116 PMCid:PMC7153362
Cattalini M, Della Paolera S, Zunica F et al. (2021). Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during epidemic in Italy: results from a national, multicenter survey. Pediatr Rheumatol. 19 (1): 29. https://doi.org/10.1186/s12969-021-00511-7; PMid:33726806 PMCid:PMC7962084
Consiglio CR, Cotugno N, Sardh F et al. (2020). The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell. 183 (4): 968-981. https://doi.org/10.1016/j.cell.2020.09.016; PMid:32966765 PMCid:PMC7474869
Dallan C, Romano F, Siebert J et al. (2020). Septic shock presentation in adolescents with COVID-19. Lancet Child Adolesc Health. 4 (7): e21-e23. https://doi.org/10.1016/S2352-4642(20)30164-4; PMid:32442421
Dong Y et al. (2020). Epidemiology of COVID-19 Among Children in China. Pediatrics. 145 (6): e20200702. https://doi.org/10.1542/peds.2020-0702; PMid:32179660
Drannyk HM, Prylutskyi OS, Bazhora YuI, Kresiun VI, Hodziieva IM, Chopiak VV et al. (2006). Clinical immunology and allergology. Edited by H.M. Drannуk. Kyiv: Health: 888.
Dubel R, Ruszel K, Chodun W, Nieradko-Iwanicka B. (2021). PIMS-TS- (Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2) - a new challenging medical condition. Journal of Education, Health and Sport. 11 (9): 11-16. https://doi.org/10.12775/JEHS.2021.11.09.001
Elakabawi K, Lin J, Jiao F et al. (2020). Kawasaki disease: global burden and genetic background. Cardiol Res. 11; 1: 9-14. https://doi.org/10.14740/cr993; PMid:32095191 PMCid:PMC7011927
Elias MD, McCrindle BW, Larios G et al. (2020). Management of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Survey From the International Kawasaki Disease Registry. CJC Open. 2 (6): 632-640. https://doi.org/10.1016/j.cjco.2020.09.004; PMid:32935083 PMCid:PMC7484693
Feldstein LR, Rose EB, Horwitz SM et al. (2020). Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N. Engl. J. Med. 383 (4): 334-346. https://doi.org/10.1056/NEJMoa2021680; PMid:32598831 PMCid:PMC7346765
Godfred-Cato S, Bryant B, Leung J et al. (2020). COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 69 (32): 1074-1080. https://doi.org/10.15585/mmwr.mm6932e2; PMid:32790663 PMCid:PMC7440126
Grimaud M, Starck J, Levy M et al. (2020). Acute myocarditis and multisystem inflammatory emerging disease following following SARS-CoV-2 infection in critically ill children. Ann Intensive Care. 10 (1): 69. https://doi.org/10.1186/s13613-020-00690-8; PMid:32488505 PMCid:PMC7266128
Gruber CN, Patel RS, Trachtman R et al. (2020). Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). Cell. 183 (4): 982-995. https://doi.org/10.1016/j.cell.2020.09.034; PMid:32991843 PMCid:PMC7489877
Guzik TJ, Mohiddin SA, Dimarco A et al. (2020). COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 116 (10): 1666-1687. https://doi.org/10.1093/cvr/cvaa106; PMid:32352535 PMCid:PMC7197627
Hoffmann M, Kleine-Weber H, Schroeder S et al. (2020). SARS-CoV-2 cell entry depends on ACE-2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181 (2): 271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052; PMid:32142651 PMCid:PMC7102627
Kabeerdoss J, Pilania RK, Karkhele R et al. (2021). Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int. 41 (1): 19-32. https://doi.org/10.1007/s00296-020-04749-4; PMid:33219837 PMCid:PMC7680080
Kappanayil M, Balan S, Alawani S et al. (2021). Multisystem inflammatory syndrome in a neonate, temporally associated with prenatal exposure to SARS-CoV-2: a case report. Lancet Child Adolesc Health. 5 (4): 304-308. https://doi.org/10.1016/S2352-4642(21)00055-9; PMid:33675696
Kaushik S, Aydin SI, Derespina KR et al. (2020). Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City. J Pediatr. 224: 24-29. https://doi.org/10.1016/j.jpeds.2020.06.045; PMid:32553861 PMCid:PMC7293760
Kone-Paut I, Cimaz R, Herberg J et al. (2018). The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series. Autoimmun Rev. 17 (8): 768-774. https://doi.org/10.1016/j.autrev.2018.01.024; PMid:29885546
Kumrah R, Vignesh P, Rawat A, Singh S. (2020). Immunogenetics of Kawasaki disease. Clin Rev Allergy Immunol. 59 (1): 122-139. https://doi.org/10.1007/s12016-020-08783-9; PMid:32200494
Licciardi F, Pruccoli G, Denina M et al. (2020). SARS-CoV-2 Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children. Pediatrics. 146; 2: e20201711. https://doi.org/10.1542/peds.2020-1711; PMid:32439816
Maly V, Delikatna T, Asoyan I. (2022). Kawasaki-like multisystem inflammatory syndrome associated with COVID-19 in children and adults. Infectious Diseases. 2: 46-57. https://doi.org/10.11603/1681-2727.2022.2.13189
Minckas N, Medvedev MM, Adejuyigbe EA, Brotherton H. (2021). Preterm care during the COVID-19 pandemic: A comparative risk analysis of neonatal deaths averted by kangaroo mother care versus mortality due toinfection. EClinicalMedicine. 33 (2): 100733. https://doi.org/10.1016/j.eclinm.2021.100733; PMid:33748724 PMCid:PMC7955179
MOZ Ukrainy. (2020). V urazhenomu koronavirusom rehioni kilkist ditei z symptomamy ridkisnoho syndromu zrosla u 30 raziv. URL: https://tsn.ua/nauka_it/koronavirus-viklikaye-u-ditey-simtomi-ridkisnogo-sindromu-vcheni-znayut-lishe-odin.
Nagelkerke SQ, Tacke CE, Breunis WB et al. (2019). Extensive ethnic variation and linkage disequilibrium at the FCGR2/3 locus: different genetic associations revealed in Kawasaki disease. Front Immunol. 10: 185. https://doi.org/10.3389/fimmu.2019.00185; PMid:30949161 PMCid:PMC6437109
Peng C, Luo Y-J, Xing Q-L et al. (2016). Clinical features of children with incomplete Kawasaki disease. CJCP. 18 (11): 1111-1114.
Qi S, Qian F, Zhang S, Zhang Z. (2020). Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochemical and Biophysical Research Communications. 526 (1): 135-140. https://doi.org/10.1016/j.bbrc.2020.03.044; PMid:32199615 PMCid:PMC7156119
Rao SPN, Minckas N, Medvedev MM, Gathara D et al. (2020). Small and sick newborn care during the COVID-19 pandemic: global survey and thematic analysis of healthcare providers' voices and experiences). BMJ Glob Health. 6 (3): e004347. https://doi.org/10.1136/bmjgh-2020-004347; PMid:33716220 PMCid:PMC7959239
Rasmussen S, Smulian J, Lednicky J et al. (2020). Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know. American Journal of Obstetrics and Gynecology. 2 (5): 415-426. Epub 2020 Feb 24. https://doi.org/10.1016/j.ajog.2020.02.017; PMid:32105680 PMCid:PMC7093856
Rodriguez-Gonzalez M, Castellano-Martinez A, Cascales-Poyatos HM, Perez-Reviriego AA. (2020). Cardiovascular impact of COVID-19 with a focus on children: A systematic review. World J Clin Cases. 8 (21): 5250-5283. https://doi.org/10.12998/wjcc.v8.i21.5250; PMid:33269260 PMCid:PMC7674714
Royal College of Pediatrics and Child Health. (2020, May 1). Guidance: Pediatric multisystem inflammatory syndrome temporally associated with COVID-19. URL: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf.
Rubattu S, Volpe M. (2019). Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics. Int. J. Mol. Sci. 20 (16): 3991. https://doi.org/10.3390/ijms20163991; PMid:31426320 PMCid:PMC6721730
Shchendrygina A, Nagel E, Puntmann VO, Valbuena-Lopez S. (2021). COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. 19 (1): 5-14. https://doi.org/10.1080/14779072.2021.1844005; PMid:33119418
Stephenson T, Allin B, Nugawela MD, Rojas N, Dalrymple E et al. (2022). Long-COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child. 107 (7): 674-680. Epub. 2022, Apr. 1. https://doi.org/10.1136/archdischild-2021-323624; PMid:35365499 PMCid:PMC8983414
Tagarro A, Epalza C, Santos M et al. (2020). Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. JAMA Pediatr: e201346. doi: 10.1001/jamapediatrics.2020.1346. Epub ahead of print. Erratum in: JAMA Pediatr. 2020 Oct 1; 174 (10): 1009. PMID: 32267485; PMCID: PMC7142799.
Volianskyi A. (2021). COVID, long-COVID and post-COVID in pediatric practice. Kyiv: Your health. URL: https://www.vz.kiev.ua/covid-long-covid-ta-post-covid-u-peduatrychnij-praktyfas/.
Wang X, Zhou Z, Zhang J et al. (2020). A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery. Clinical Infectious Diseases. 71; 15: 844-846. doi: https://doi.org/10.1093/cid/ciaa200; PMid:32119083 PMCid:PMC7108126
Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. (2020, Apr 7). Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA. 323 (13): 1313-1314. https://doi.org/10.1001/jama.2020.2131; PMid:32058570 PMCid:PMC7042807
Whittaker E, Bamford A, Kenny J et al. (2020). Clinical Characteristicsof 58 Children With a Pediatric Inflammatory Multisystem Syndrome. Temporally Associated With SARS-CoV-2. JAMA. 324 (3): 259-269. https://doi.org/10.1001/jama.2020.10369; PMid:32511692 PMCid:PMC7281356
Zhang J, Wang Y, Chen L et al. (2003). Clinical analysis of pregnancy in second and third trimesters complicated severe acute respiratory syndrome. Zhonghua Fu Chan Ke Za Zhi. 38: 516-520.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
